PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18373979-1	2008	Genetic variation in human N-acetyltransferases (NAT) has been implicated in susceptibility to aromatic amine and hydrazine carcinogens and therapeutic drugs.	aromatic amine	95-109	bromodomain containing 2	Homo sapiens	27-47	
18373979-1	2008	Genetic variation in human N-acetyltransferases (NAT) has been implicated in susceptibility to aromatic amine and hydrazine carcinogens and therapeutic drugs.	aromatic amine	95-109	bromodomain containing 2	Homo sapiens	49-52	
9477228-0	1998	Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.	aromatic amine	24-38	bromodomain containing 2	Homo sapiens	142-161	
3209851-1	1988	The human polymorphism in the hepatic enzyme N-acetyltransferase (NAT) affects the rate at which individuals acetylate, and in many cases detoxify, aromatic amine and hydrazine drugs and xenobiotics.	aromatic amine	148-162	bromodomain containing 2	Homo sapiens	66-69	
33537010-13	2020	These results showed that (VIBVN)NAT could acetylate various aromatic amine substrates and contribute to arylamine antibiotic resistance in V. vulnificus.	aromatic amine	61-75	bromodomain containing 2	Homo sapiens	33-36